吉兰-巴雷综合征预后相关因素的研究进展  

Research Progress on Prognostic Factors of Guillain-Barre Syndrome

作　　者：贾飞鸿 范学慧 钟镝[1] 李国忠[1] 赵秀丽[1] JIA Fei-hong;FAN Xue-hui;ZHONG Di;LI Guo-zhong;ZHAO Xiu-li(Department of Neurology,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)

机构地区：[1]哈尔滨医科大学附属第一医院神经内科,哈尔滨150001

出　　处：《中国临床神经科学》2022年第1期106-111,共6页Chinese Journal of Clinical Neurosciences

基　　金：哈医大一院科研基金(编号:2011BS012)。

摘　　要：吉兰-巴雷综合征(GBS)是一类常见的导致急性弛缓性瘫痪的免疫性周围神经病。一般具有自限性,部分患者遗留长期残疾,临床早期发现、个性化治疗对预后具有重要意义。文中对近年GBS与预后相关的临床评分系统、生物标志物、神经电生理及治疗等研究进展进行综述,旨在为临床诊疗提供参考。Guillain-Barré syndrome(GBS) is a common type of immune peripheral neuropathy leading to acute flaccid paralysis with self-limited and long-term disability some patients. Early clinical discovery and personalized treatment are of great significance to prognosis. The clinical scoring system,biomarkers, neuroelectrophysiology and treatment related to prognosis in recent years were reviewed.

关 键 词：吉兰-巴雷综合征 预后 临床评分系统 生物标志物 神经电生理 治疗 

分 类 号：R745[医药卫生—神经病学与精神病学]